You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Drug delivery to delay delivery
Preterm birth, often caused by inflammation, is a major contributor to infant morbidity and mortality. It often cannot be predicted, but even for women who are known to be at risk of preterm delivery, there is no currently approved intervention to prevent it, although progesterone-based interventions are sometimes attempted. To improve access of treatments to the appropriate tissues for preventing preterm delivery, Zierden et al. designed a mucoinert nanosuspension to optimize vaginal dosing of therapeutics. The authors demonstrated the effectiveness of their approach in mouse models using histone deacetylase inhibitors with and without progesterone. Their approach improved the rates of full-term delivery of neurotypical pups.
- Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.
